Several studies reported that PGE2, when binding to its receptor EP2, can activate the NF-κB pathway in an ovarian cancer cell model (SKOV3 and OVCAR3) [81] and in a mouse model of intracranial aneurysm [27]. This evidence concerns the gene NFKB1 and ovarian carcinoma.